Rank
|
HUGO
|
Symbol
|
Target Name
|
#Occur
|
#Paper
|
Matched_Terms
|
MiMI
|
BG#1 paper
|
p-value
|
p-value (BH)
|
BG#2 paper
|
p-value
|
p-value (BH)
|
BG#3 paper
|
p-value
|
p-value (BH)
|
1 | 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 2479 | 368 | superoxide dismutase | superoxide dismutase 1 | SOD-superoxide | Sod1 | SOD-1 | SOD1 | SOD-determination | SOD-supplemented | SOD-mimetics | SOD-deficient | SOD-mimetic | SOD-treated | SOD-induced | SODs | hSOD | SOD-like | SOD-mediated | SOD-inhibitable | SOD1-specific | SOD-transduced | ALS | SOD-sensitive | SOD-injected | SOD-dependent | SOD-exposed | | 31 | 2.98E-087 | 3.05E-084 | 38 | 1.98E-081 | 2.03E-078 | 38 | 1.98E-081 | 2.03E-078 |
2 | 1516 | CAT | catalase | 1424 | 241 | catalase | CAT | CAT-reversible | | 22 | 4.12E-053 | 2.11E-050 | 30 | 7.66E-047 | 3.93E-044 | 30 | 7.66E-047 | 3.93E-044 |
3 | 14874 | NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | 1393 | 177 | nadph oxidase | Nox5 | NOX5 | | 9 | 9.01E-045 | 3.08E-042 | 12 | 1.39E-041 | 3.55E-039 | 14 | 8.10E-040 | 2.08E-037 |
4 | 6081 | INS | insulin | 4605 | 503 | insulin | proinsulin | proinsulin-like | INS | | 201 | 2.31E-043 | 5.94E-041 | 193 | 5.70E-046 | 1.95E-043 | 205 | 6.63E-042 | 2.27E-039 |
5 | 12805 | XDH | xanthine dehydrogenase | 375 | 133 | xanthine oxidase | xanthine dehydrogenase | xanthine oxidoreductase | XOR | | 7 | 7.16E-033 | 1.47E-030 | 9 | 5.65E-031 | 1.16E-028 | 10 | 4.30E-030 | 8.83E-028 |
6 | 9393 | PRKCA | protein kinase C, alpha | 491 | 194 | protein kinase c | pkc alpha | protein kinase c alpha | PKCA | PKC-A | PRKCA | PKC-alpha | PKCI | PKC-alpha-dependent | | 46 | 4.17E-025 | 7.14E-023 | 40 | 3.74E-028 | 6.39E-026 | 44 | 5.18E-026 | 8.86E-024 |
7 | 7660 | NCF1 | neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1) | 602 | 72 | p47 protein | neutrophil cytosolic factor 1 | NCF1 | P47- | p47phox-containing | Ncf1 | p47phox-dependent | p47phox-induced | | 1 | 5.15E-021 | 7.55E-019 | 4 | 6.79E-018 | 7.74E-016 | 4 | 6.79E-018 | 8.70E-016 |
8 | 7876 | NOS3 | nitric oxide synthase 3 (endothelial cell) | 1993 | 115 | endothelial nitric oxide synthase | eNOS-mediated | eNOS-generated | eNOS-associated | NOS-mediated | eNOS-expression | eNOS-knockout | eNOS-specific | eNOS-induced | NOS-3 | ecNOS | eNOS-dependent | NOS3 | eNOS-independent | eNOS-related | eNOS-containing | eNOS-derived | eNOS-driven | eNOS-deficient | | 16 | 1.26E-020 | 1.62E-018 | 20 | 2.66E-018 | 3.90E-016 | 17 | 5.16E-020 | 7.56E-018 |
9 | 11180 | SOD2 | superoxide dismutase 2, mitochondrial | 817 | 85 | mn sod | manganese superoxide dismutase | mn superoxide dismutase | superoxide dismutase 2 | SOD2- | MnSod | SOD-2 | Mn-SOD- | MnSOD-expressing | MnSOD-deficient | sod2 | Sod2 | MnSOD-transduced | | 5 | 1.81E-020 | 2.06E-018 | 8 | 6.02E-018 | 7.73E-016 | 9 | 3.29E-017 | 3.76E-015 |
10 | 2577 | CYBA | cytochrome b-245, alpha polypeptide | 436 | 69 | p22 phox | p22phox | p22-phox | p22phox-mediated | p22phox-containing | CYBA | | 2 | 4.13E-019 | 4.24E-017 | 6 | 4.84E-015 | 4.97E-013 | 5 | 7.43E-016 | 6.93E-014 |
11 | 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | 932 | 144 | nitric oxide synthase | NOS-dependent | iNOS-positive | NOS-inhibitor | NOS-independent | Nos2 | iNOS-knockout | iNOS-expressing | iNOS-expression | iNOS-mediated | NOS2A | NOS2 | iNOS-dependent | iNOS-selective | iNOS-deficient | NOS-2 | | 35 | 4.14E-018 | 3.86E-016 | 46 | 6.12E-014 | 5.23E-012 | 40 | 4.36E-016 | 4.47E-014 |
12 | 333 | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 1997 | 131 | angiotensin ii | ang ii | angiotensinogen | ang i | angiotensin i | Ang-II-dependent | Ang-II-induced | Agt | AngII | AngII-mediated | ANG | AGT | AngI | Ang-II-infused | AngII-like | | 32 | 2.08E-016 | 1.78E-014 | 46 | 2.20E-011 | 1.41E-009 | 51 | 5.87E-010 | 3.54E-008 |
13 | 381 | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) | 157 | 61 | aldose reductase | AKR1B1 | ALR2 | | 4 | 1.02E-014 | 8.03E-013 | 4 | 1.02E-014 | 9.50E-013 | 6 | 4.19E-013 | 3.58E-011 |
14 | 2578 | CYBB | cytochrome b-245, beta polypeptide (chronic granulomatous disease) | 463 | 49 | gp91 phox | p91 phox | NOX2-Deficient | gp91phox-containing | CYBB | Nox2-containing | Nox-2 | gp-91-phox | NOX-2 | NOX2-deficient | Cybb | Nox2-Containing | nox2-dependent | CGD | Nox2-deficient | NOX2-containing | Nox2-derived | | 1 | 5.50E-014 | 4.03E-012 | 4 | 4.54E-011 | 2.59E-009 | 2 | 7.30E-013 | 5.76E-011 |
15 | 7872 | NOS1 | nitric oxide synthase 1 (neuronal) | 878 | 82 | neuronal nitric oxide synthase | nNOS-containing | NOS-dependent | NOS-1 | nNOS-independent | nNOS-positive | NOS-inhibitor | nNOS-deficient | nNOS-dependent | NOS-positive | NOS-independent | NOS-like | nNOS-mediated | NOS-immunoreactive | NOSs | NOS-inhibition | NOS-Mediated | NOS-specific | NOS-derived | nNOS-negative | nNOS-immunoreactive | NOS1-deficient | NOS-selective | NOS-knockout | nNOS-derived | | 13 | 7.18E-014 | 4.91E-012 | 17 | 5.03E-012 | 3.68E-010 | 19 | 6.80E-011 | 4.65E-009 |
16 | 7661 | NCF2 | neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) | 205 | 50 | chronic granulomatous disease | p67 phox | p67phox | p67-phox | NCF2 | | 2 | 3.71E-013 | 2.38E-011 | 4 | 2.40E-011 | 1.45E-009 | 6 | 6.67E-010 | 3.80E-008 |
17 | 19986 | CYCS | cytochrome c, somatic | 308 | 81 | cytochrome c | | 17 | 1.45E-011 | 8.72E-010 | 16 | 2.84E-012 | 2.24E-010 | 16 | 2.84E-012 | 2.08E-010 |
18 | 4827 | HBB | hemoglobin, beta | 442 | 101 | beta globin | hemoglobin | | 31 | 2.46E-010 | 1.40E-008 | 27 | 8.56E-012 | 5.85E-010 | 32 | 3.45E-010 | 2.21E-008 |
19 | 4623 | GSR | glutathione reductase | 141 | 61 | glutathione reductase | | 10 | 2.62E-010 | 1.41E-008 | 11 | 8.92E-010 | 4.82E-008 | 11 | 8.92E-010 | 4.82E-008 |
20 | 12517 | UCP1 | uncoupling protein 1 (mitochondrial, proton carrier) | 325 | 38 | uncoupling protein 1 | UCPs | UCP1 | UCP-1_amp_#x02013 | UCP1-expressing | UCP-1 | UCP1-overexpressing | | 3 | 8.05E-009 | 4.13E-007 | 4 | 4.41E-008 | 2.06E-006 | 5 | 1.98E-007 | 9.65E-006 |
21 | 7891 | NOX4 | NADPH oxidase 4 | 371 | 31 | NOX-4 | Nox4-containing | Nox4-derived | Nox4-transfected | nox4 | Nox-4 | NOX4 | nox-4 | Renox | Nox4-treated | | 1 | 1.27E-008 | 6.20E-007 | 5 | 6.41E-006 | 2.27E-004 | 3 | 6.48E-007 | 2.66E-005 |
22 | 270 | PARP1 | poly (ADP-ribose) polymerase family, member 1 | 460 | 37 | poly adp ribose synthetase | poly adp ribose polymerase | parp 1 | dna repair enzyme | poly adp ribose polymerase 1 | PARP | PARP-induced | PARP-1 | PARP-deficient | PARP-1_amp_#x02013 | PARPs | PARP-mediated | | 3 | 1.52E-008 | 7.08E-007 | 2 | 2.18E-009 | 1.12E-007 | 6 | 1.33E-006 | 5.25E-005 |
23 | 12518 | UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) | 434 | 34 | uncoupling protein 2 | UCP2-mediated | UCP2-upregulated | UCP2-overexpressing | Ucp2-deficient | ucp2 | UCP2-deficient | UCP-2 | UCP2-regulated | | 2 | 1.56E-008 | 6.95E-007 | 3 | 1.00E-007 | 4.48E-006 | 4 | 4.98E-007 | 2.13E-005 |
24 | 4823 | HBA1 | hemoglobin, alpha 1 | 86 | 30 | HB-A | HBA1 | HbA1 | HbA | HBA | Hba1 | | 1 | 2.49E-008 | 1.07E-006 | 1 | 2.49E-008 | 1.22E-006 | 2 | 2.09E-007 | 9.30E-006 |
25 | 399 | ALB | albumin | 550 | 179 | albumin | serum albumin | | 97 | 1.71E-007 | 7.00E-006 | 96 | 1.14E-007 | 4.87E-006 | 93 | 3.26E-008 | 1.67E-006 |
26 | 7889 | NOX1 | NADPH oxidase 1 | 262 | 30 | mitogenic oxidase | gp91 2 | nadph oxidase 1 | NOX-derived | nox1 | NOX-mediated | NOX-1 | Nox1-derived | Mox1 | nox-1 | NOX1 | MOX-1 | Nox-1 | NOXs | Nox1-generated | NOX-knockout | NOX-dependent | Mox-1 | Nox1-containing | | 2 | 2.09E-007 | 8.23E-006 | 2 | 2.09E-007 | 8.56E-006 | 2 | 2.09E-007 | 9.72E-006 |
27 | 7794 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 792 | 90 | nf kappa b | nuclear factor kappa b | nfkb p50 | NFKB1 | NF-kappaB-induced | NF-kappaB-controlled | NF-kB | NF-kappaB-dependent | p105 | NF-kappaB-mediated | NFkB | NF-kappaB-specific | NF-kappaB-activated | | 34 | 2.48E-007 | 9.42E-006 | 39 | 3.18E-006 | 1.21E-004 | 41 | 1.28E-005 | 4.53E-004 |
28 | 12680 | VEGFA | vascular endothelial growth factor A | 956 | 57 | vascular endothelial growth factor | vascular permeability factor | vascular endothelial growth factor a | vegf a | VEGF-dependent | VEGFA | Vegf | Vegf-A | VEGF-stimulated | VEGF-neutralizing | VEGF-unrelated | VEGF-induced | VEGF-mediated | VEGF-A | VEGF-treated | VEGF-A-induced | | 19 | 7.03E-006 | 2.57E-004 | 18 | 5.16E-006 | 1.89E-004 | 23 | 1.41E-004 | 4.14E-003 |
29 | 11181 | SOD3 | superoxide dismutase 3, extracellular | 411 | 18 | extracellular superoxide dismutase | extracellular superoxide dismutase ec sod | ECSOD | SOD3 | EC-SOD | | 0 | 7.14E-006 | 2.52E-004 | 4 | 4.17E-003 | 8.07E-002 | 3 | 1.42E-003 | 3.39E-002 |
30 | 9958 | REN | renin | 117 | 51 | renin | | 16 | 1.07E-005 | 3.64E-004 | 23 | 8.97E-004 | 2.19E-002 | 26 | 3.73E-003 | 7.22E-002 |
31 | 7218 | MPO | myeloperoxidase | 227 | 28 | myeloperoxidase | MPO-amplified | MPO-dependent | MPO-deficient | MPO-induced | MPO-derived | MPO-catalyzed | MPO-mediated | | 4 | 1.71E-005 | 5.65E-004 | 12 | 1.57E-002 | 2.37E-001 | 9 | 2.37E-003 | 5.07E-002 |
32 | 11184 | SORD | sorbitol dehydrogenase | 32 | 15 | sorbitol dehydrogenase | SDH | | 0 | 5.83E-005 | 1.81E-003 | 0 | 5.83E-005 | 1.93E-003 | 0 | 5.83E-005 | 1.81E-003 |
33 | 2202 | COL4A1 | collagen, type IV, alpha 1 | 126 | 15 | collagen iv | | 0 | 5.83E-005 | 1.76E-003 | 1 | 4.98E-004 | 1.28E-002 | 0 | 5.83E-005 | 1.76E-003 |
34 | 11765 | TGFA | transforming growth factor, alpha | 62 | 46 | transforming growth factor | | 15 | 7.15E-005 | 2.09E-003 | 20 | 1.60E-003 | 3.48E-002 | 13 | 9.50E-006 | 3.48E-004 |
35 | 2707 | ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 200 | 69 | angiotensin converting enzyme | kininase ii | angiotensin i converting enzyme | ACE | ACE-independent | ACE-inhibitors | | 31 | 1.32E-004 | 3.75E-003 | 34 | 3.99E-004 | 1.11E-002 | 34 | 3.99E-004 | 1.11E-002 |
36 | 336 | AGTR1 | angiotensin II receptor, type 1 | 123 | 36 | angiotensin ii receptor | AGTR1 | AT1-receptor | AT1R | Agtr1 | | 10 | 1.35E-004 | 3.74E-003 | 14 | 2.34E-003 | 4.90E-002 | 9 | 5.61E-005 | 1.80E-003 |
37 | 4057 | G6PD | glucose-6-phosphate dehydrogenase | 59 | 19 | glucose 6 phosphate dehydrogenase | glucose 6 phosphate dehydrogenase g6pd | G6PD | | 2 | 2.08E-004 | 5.62E-003 | 7 | 2.81E-002 | 3.65E-001 | 6 | 1.41E-002 | 2.10E-001 |
38 | 2295 | CP | ceruloplasmin (ferroxidase) | 22 | 13 | ceruloplasmin | ferroxidase | | 0 | 2.36E-004 | 6.21E-003 | 3 | 2.08E-002 | 3.10E-001 | 3 | 2.08E-002 | 2.89E-001 |
39 | 7662 | NCF4 | neutrophil cytosolic factor 4, 40kDa | 28 | 16 | p40 | p40phox | | 1 | 2.62E-004 | 6.73E-003 | 0 | 2.90E-005 | 9.90E-004 | 0 | 2.90E-005 | 9.90E-004 |
40 | 7427 | MT-CYB | mitochondrially encoded cytochrome b | 47 | 15 | cytochrome b | | 1 | 4.98E-004 | 1.25E-002 | 1 | 4.98E-004 | 1.31E-002 | 3 | 7.32E-003 | 1.29E-001 |
41 | 3062 | DUOX1 | dual oxidase 1 | 23 | 11 | nicotinamide adenine dinucleotide phosphate oxidas | dual oxidase 1 | Duox1 | DUOX1 | | 0 | 9.54E-004 | 2.22E-002 | 2 | 2.21E-002 | 2.94E-001 | 1 | 6.22E-003 | 1.12E-001 |
42 | 8583 | SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 948 | 37 | plasminogen activator inhibitor | plasminogen activator inhibitor 1 | pai 1 | PAI-1-deficient | SERPINE1 | | 14 | 1.06E-003 | 2.36E-002 | 14 | 1.06E-003 | 2.52E-002 | 9 | 3.42E-005 | 1.13E-003 |
43 | 25806 | GSTCD | glutathione S-transferase, C-terminal domain containing | 53 | 37 | glutathione s transferase | | 14 | 1.06E-003 | 2.41E-002 | 20 | 3.10E-002 | 3.79E-001 | 16 | 4.97E-003 | 9.11E-002 |
44 | 2244 | COQ7 | coenzyme Q7 homolog, ubiquinone (yeast) | 55 | 16 | coenzyme q | | 2 | 1.26E-003 | 2.75E-002 | 4 | 1.15E-002 | 1.93E-001 | 2 | 1.26E-003 | 3.08E-002 |
45 | 9801 | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 126 | 18 | Rac-1 | rac1 | RAC1 | rac1-induced | Rac1 | | 3 | 1.42E-003 | 3.04E-002 | 7 | 4.22E-002 | 4.33E-001 | 4 | 4.17E-003 | 7.78E-002 |
46 | 6834 | MAOB | monoamine oxidase B | 18 | 10 | amine oxidase | | 0 | 1.92E-003 | 3.85E-002 | 2 | 3.81E-002 | 4.07E-001 | 2 | 3.81E-002 | 4.39E-001 |
47 | 12519 | UCP3 | uncoupling protein 3 (mitochondrial, proton carrier) | 655 | 17 | uncoupling protein 3 | UCP-3 | UCP3-ablated | UCP3-mediated | UCP3-induced | UCP3-transfected | UCP3-deficient | | 3 | 2.47E-003 | 4.70E-002 | 2 | 6.96E-004 | 1.74E-002 | 2 | 6.96E-004 | 1.78E-002 |
48 | 12663 | VCAM1 | vascular cell adhesion molecule 1 | 175 | 29 | vascular cell adhesion molecule 1 | VCAM1 | Vcam1 | VCAM-1 | | 10 | 3.12E-003 | 5.43E-002 | 10 | 3.12E-003 | 6.28E-002 | 9 | 1.52E-003 | 3.54E-002 |
49 | 391 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 592 | 75 | protein kinase b | pkb alpha | AKT-mediated | rac | Akt-1 | Rac-1-independent | Rac-regulated | Akt-regulated | Akt-independent | AKT-insensitive | AKT1 | PKB-dependent | PKB-independent | AKT-phosphorylated | Akt-signaling | Rac-1-expressing | Akt-Forkhead | Akt-kinase | | 43 | 3.24E-003 | 5.54E-002 | 42 | 2.27E-003 | 4.85E-002 | 43 | 3.24E-003 | 6.39E-002 |
50 | 6554 | LEPR | leptin receptor | 50 | 21 | leptin receptor | LEPR | Lepr | | 6 | 5.65E-003 | 8.65E-002 | 8 | 2.33E-002 | 3.06E-001 | 4 | 5.01E-004 | 1.35E-002 |
51 | 3176 | EDN1 | endothelin 1 | 491 | 38 | endothelin 1 | ET-1 | EDN1 | | 17 | 5.85E-003 | 8.82E-002 | 21 | 3.40E-002 | 3.75E-001 | 14 | 1.05E-003 | 2.63E-002 |
52 | 2197 | COL1A1 | collagen, type I, alpha 1 | 634 | 84 | collagen i | collagen-induced | collagen-specific | | 52 | 5.96E-003 | 8.73E-002 | 47 | 1.13E-003 | 2.63E-002 | 54 | 1.07E-002 | 1.68E-001 |
53 | 10618 | CCL2 | chemokine (C-C motif) ligand 2 | 291 | 38 | monocyte chemotactic protein 1 | monocyte chemoattractant protein 1 | mcp 1 | Ccl2 | MCP-1 | | 19 | 1.51E-002 | 1.96E-001 | 16 | 2.38E-003 | 4.89E-002 | 13 | 3.55E-004 | 1.01E-002 |